Novocure is dedicated to supporting impartial organizations with shared ambitions relevant to advancing healthcare care and strengthening individual results.
LUNAR is usually a phase three demo tests the protection and effectiveness of TTFields therapy when applied together with ICI or docetaxel (experimental arm) as opposed to ICI or docetaxel alone (Regulate arm) for clients with metastatic NSCLC who progressed in the course of or after platinum-dependent therapy. It is approximated that close to 46,000 individuals receive second-line procedure for metastatic NSCLC each and every year within the U.S. The primary endpoint is excellent Total survival of patients addressed with TTFields therapy moreover ICI or docetaxel versus ICI or docetaxel by yourself.
Tempo de registro: prefira sempre empresas que já estejam no mercado há mais tempo, é comum que web sites fraudulentos tenham pouco tempo de vida;
about us our therapy our products our pipeline Trader relations Professions news and media affected individual-forward Speak to us
Novocure is devoted to supporting impartial organizations with shared goals related to advancing professional medical care and enhancing affected person outcomes.
see presentation about us our story our leadership company presentation advocacy ESG exterior funding our therapy our merchandise Optune Gio® Optune Lua® our pipeline our pipeline novocuretrials.com Trader relations investor relations home stock information corporate presentation SEC filings press releases company governance careers information and media information and media press kit push releases picture gallery affected individual-forward individual-ahead Added Information corporate compliance california customer privacy detect privacy see hipaa privacy notice terms and conditions web site map novocure vulnerability disclosure procedure On This page, videos and images discovered as Optune users, caregivers or healthcare specialists depict real patients, caregivers and healthcare pros. Affected person images mirror the health status on the sufferers at time each Photograph or video was taken.
Trader relations dwelling inventory facts corporate presentation SEC filings press releases corporate governance
Will you be sure you need to continue? This hyperlink will navigate you to definitely an exterior Internet site beyond Novocure.com. Terminate Continue on
Novocure has submitted the LUNAR scientific trial results for publication in a leading, peer-reviewed health care journal. The LUNAR scientific trial knowledge are predicted to function the basis to get a Premarket Acceptance (PMA) submission into the U.S. Food stuff and Drug Administration in the second 50 percent of 2023.
the inspiration of rely on supporting sufferers in Israel As our the first Make contact with from Novocure for sufferers in Israel, Karen Huller aims to empathize and make a reliable relationship. supporting individuals in Israel reinventing our to start with contact with patients When his ally was diagnosed with cancer, Nicholas Doucette made a decision to dedicate his Expert lifetime to assisting most cancers sufferers. reinventing our to start with connection with people why innovation normally takes braveness Joachim thinks that at the center of each innovation is courage. He communicates the stories of his colleagues to motivate others. why innovation normally takes braveness supporting investigators in TTFields scientific trials As numerous doctors are utilizing TTFields therapy for The very first time to treat their sufferers in nervocure é confiavel medical trials, Jonathan Gephart educates them over the science and administration of TTFields therapy. supporting investigators in TTFields scientific trials
In 2000, Yoram Palti, our founder and professor emeritus of physiology and biophysics at the Technion — Israel Institute of Engineering, sought to leverage his knowledge in biophysics to establish a brand new way to take care of reliable tumor cancers that will destroy tumor cells though sparing nutritious tissue and steering clear of many of the existence-altering Unintended effects of current cancer therapies.
Together with our patients, we try to increase survival in a few of the most aggressive types of cancer by creating and commercializing our impressive therapy. Find out more about our Tale, from our founding in Haifa, Israel in 2000 to getting grown into a global oncology business now.
Novocure is a world oncology corporation Performing to increase survival in many of the most aggressive forms of most cancers through the event and commercialization of its ground breaking therapy, Tumor Dealing with Fields. Novocure’s commercialized merchandise are authorised in selected nations for the remedy of Grownup sufferers with glioblastoma, malignant pleural mesothelioma and pleural mesothelioma.
We sign up for along with individuals, caregivers and advocacy partners inside their perseverance to redefine residing with cancer.